Latest news with #Fisher&PaykelHealthcare
NZ Herald
23-07-2025
- Business
- NZ Herald
New Zealand sharemarket dips as F&P Healthcare, Infratil shares fall
New Zealand's largest stock, Fisher & Paykel Healthcare, fell for a second day after it hosted an investor day in Melbourne, although Goodson said there was no real news for Kiwi investors. F&P shares fell 28c to $36.41, after 328,025 shares changed hands, worth $11,918,976.27. Meanwhile, Infratil shares fell 2.45% to $11.17. 'The other key name in the index was down. In the Australian close last night Infratil entered the ASX 200 index, so buying in anticipation of that may now be absent and that could perhaps explain that decline,' Goodson said. Elsewhere, Sky TV continued its positive momentum following the news it had agreed to purchase TV3 for $1 on a cash-free, debt-free basis. Today, analysts at fund manager Octagon said the business will be worth 35c per share to its new owner – or just over $48m. Sky TV's share price climbed 6c to $3.12. 'It's hardly operating in growth markets. By bolting on a business like that and hopefully extracting some cost and revenue synergies in the future, they may be able to stem some of the structural pressures that they face,' Goodson said. He also pointed out the Colonial Motor Company, one of New Zealand's longest-listed companies. It had $125,212.55 worth of shares trade on light volume. The business, which owns a number of Ford dealerships and franchises around the country, released a guidance upgrade to its second-half results, saying it is shaping to contribute to a more positive outcome for the full-year trading profit after tax than was anticipated in February. 'It's not a reflection of the overall economic environment, rather pockets of the wider vehicle market. I think it's pointing to what's becoming fairly clear in this economy, which is that large parts of the rural sector are having a pretty good year or two, but that's yet filtering through to town,' Goodson said. Global markets The Nasdaq retreated from a record Tuesday on a mixed day for stocks as markets looked ahead to upcoming earnings reports from Google parent Alphabet and Tesla. The two reports on Wednesday are the first of Wall Street's 'Magnificent Seven' equities to report this season. The group was mixed, with drops in Nvidia and other semiconductor equities consistent with profit-taking after earlier gains, analysts said. The tech-rich Nasdaq fell 0.4% to 20,892.69, snapping a six-day streak of record high finishes. But the broad-based S&P 500 edged up 0.1% to 6309.62, finishing at a record, while the Dow Jones Industrial Average climbed 0.4% to 44,502.44. Art Hogan of B. Riley Wealth Management described the market as in a 'wait-and-see' mode ahead of earnings from the most influential equities. – Additional reporting AFP Tom Raynel is a multimedia business journalist for the Herald, covering small business, retail and tourism.
NZ Herald
21-07-2025
- Business
- NZ Herald
Healthcare giants drive positive day on NZ sharemarket
It means the official inflation rate is at its highest point in the last year, but the June quarter rise was lower than expected at 0.5%. Craigs Investment Partners investment director Mark Lister said the market responded positively. 'The inflation rate came in a little hotter than the Reserve Bank had expected back in May, although they will have seen everything you and I have seen since May so they would have known it was or expected it to be a little up on their May forecasts,' Lister said. 'It was a better outcome than we were expecting, which means a higher chance of that Official Cash Rate (OCR) cut that we didn't get in July, coming in August.' The kiwi and wholesale interest rates edged lower, but Lister said the share market continued to perform strongly as it approached its highest point since February. On the main board, healthcare companies Fisher & Paykel Healthcare and Ebos Group performed strongly. Fisher & Paykel Healthcare shares rose 1.45% to $37.07, after 164,162 shares changed hands to the value of $6,068,529.05. While Ebos Group shares rose 0.88% to $40.15, after shares worth $6,656,789.81 were traded. 'We're all hopeful that Fisher & Paykel Healthcare will escape the worst of the potential tariffs. 'There was still a lot of manufacturing in Mexico, selling to North America, and they're very much a global business. Its supply chains are highly integrated, which means they're one that we're all watching very closely as we wait for more news on the tariff front.' Infratil, meanwhile, saw its share price fall 8c to $11.47, after $5,100,425.57 worth of shares traded hands. Mainfreight's share price fell, dropping 95c to $67.00 after 58,182 shares traded hands to the value of $3,899,994.68. The world In Hong Kong equities mostly rose Monday on optimism countries will reach US trade deals before an August 1 deadline, while the yen gained after Japanese Prime Minister Shigeru Ishiba said he would stay in office despite another election defeat. Hong Kong topped 25,000 points for the first time in three years as tech giants advanced following strong earnings from Taiwanese chip giant TSMC and news US titan Nvidia would be allowed to export key semiconductors to China. While only three countries have signed agreements to avoid the worst of Donald Trump's tariffs, analysts said investors were hopeful that others – including Japan and South Korea – will follow suit. The upbeat mood has been helped by a series of largely positive US economic data releases that suggested the world's top economy remained in rude health, helping to push Wall Street to multiple record highs. In early trade, Hong Kong climbed to as high as 25,010.90 – its highest level since February 2022 – thanks to a strong performance in ecommerce leaders Alibaba and and food delivery provider Meituan. – Additional reporting AFP Tom Raynel is a multimedia business journalist for the Herald, covering small business, retail and tourism.
NZ Herald
28-05-2025
- Business
- NZ Herald
NZ sharemarket drops 1.75% as Fisher & Paykel forecast weighs on market
The New Zealand sharemarket dropped sharply today after the NZX's largest listed company, Fisher & Paykel Healthcare, reported a weaker than expected forecast. The S&P/NZX 50 Index closed down 1.75% or 220.074 points, falling to 12,362.26, with 42,962,847 shares changing hands to the value of $154.15 million. The S&P/NZX
Yahoo
22-05-2025
- Business
- Yahoo
Fisher & Paykel Healthcare (NZSE:FPH) Is Reinvesting At Lower Rates Of Return
Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key financial metrics. Typically, we'll want to notice a trend of growing return on capital employed (ROCE) and alongside that, an expanding base of capital employed. If you see this, it typically means it's a company with a great business model and plenty of profitable reinvestment opportunities. Looking at Fisher & Paykel Healthcare (NZSE:FPH), it does have a high ROCE right now, but lets see how returns are trending. This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality. Just to clarify if you're unsure, ROCE is a metric for evaluating how much pre-tax income (in percentage terms) a company earns on the capital invested in its business. To calculate this metric for Fisher & Paykel Healthcare, this is the formula: Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities) 0.20 = NZ$419m ÷ (NZ$2.4b - NZ$373m) (Based on the trailing twelve months to September 2024). So, Fisher & Paykel Healthcare has an ROCE of 20%. On its own, that's a very good return and it's on par with the returns earned by companies in a similar industry. See our latest analysis for Fisher & Paykel Healthcare In the above chart we have measured Fisher & Paykel Healthcare's prior ROCE against its prior performance, but the future is arguably more important. If you'd like to see what analysts are forecasting going forward, you should check out our free analyst report for Fisher & Paykel Healthcare . In terms of Fisher & Paykel Healthcare's historical ROCE movements, the trend isn't fantastic. While it's comforting that the ROCE is high, five years ago it was 32%. Although, given both revenue and the amount of assets employed in the business have increased, it could suggest the company is investing in growth, and the extra capital has led to a short-term reduction in ROCE. And if the increased capital generates additional returns, the business, and thus shareholders, will benefit in the long run. Even though returns on capital have fallen in the short term, we find it promising that revenue and capital employed have both increased for Fisher & Paykel Healthcare. These trends are starting to be recognized by investors since the stock has delivered a 29% gain to shareholders who've held over the last five years. So this stock may still be an appealing investment opportunity, if other fundamentals prove to be sound. If you want to continue researching Fisher & Paykel Healthcare, you might be interested to know about the 2 warning signs that our analysis has discovered. If you want to search for more stocks that have been earning high returns, check out this free list of stocks with solid balance sheets that are also earning high returns on equity. Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned. Sign in to access your portfolio
Scoop
20-05-2025
- Business
- Scoop
Plastics Industry Rising Stars Honoured At Plastics NZ Awards
Press Release – Plastics New Zealand He's not a doctor, a nurse, or even a police officer but Rajeneel Kumar helps to save lives. Named 2025 Competenz Plastics Apprentice of the Year at the annual Plastics NZ Awards on Thursday night, the Manurewa local produces critical components for lifesaving technologies – from ventilators for premature babies to sleep apnoea devices and hospital masks. 'It's pretty cool how the components we make are used to save lives – it makes the job rewarding,' says Rajeneel, who has spent over a decade at Fisher & Paykel Healthcare and last year completed his New Zealand Certificate in Plastics Processing (Level 4) with strands Injection Moulding through work based training organisation, Competenz. 'I'd worked for Fisher & Paykel Healthcare for many years before starting my apprenticeship and I thought I knew everything, but my apprenticeship challenged me to dig so much deeper. I learned so much about plastics technology.' The accolade is a 'huge thrill' for the 32 year old, who has worked tirelessly to achieve his goal. 'It hasn't been easy, especially working in the healthcare industry during Covid when we were running 24/7. I've also got two young kids, and my wife works in the afternoons so juggling the book work with family life was a big challenge. Winning Apprentice of the Year means so much to me. In 2023 I was named runner-up for Competenz Plastics Trainee of the Year, so to actually win this year is a huge thrill. It shows that all the research, all the work and all the support I was given was worth it.' Rajeneel saw gaining his apprenticeship 'as an opportunity to improve myself,' and it's a move that has certainly paid off. Now he has been promoted to Plastics Team Leader, and soon he'll be mentoring some of the young apprentices following in his footsteps. Competenz Training Advisor Alan Smith couldn't be prouder. 'Rajeneel stands out from the rest,' says Alan. 'He performs well, shows willingness to learn and is always eager to learn new technologies. He has an ambitious mindset and is keen to explore further avenues to grow in his career.' Rajeneel's future at Fisher & Paykel Healthcare is bright. Operations Engineering Manager Shijoy Sam says he is a huge asset for the business. 'Rajeneel is ambitious, keen to take on new challenges and always goes above and beyond expectations. He leads the team by example, is diligent and gives 100 percent to everything he commits to,' says Shijoy. 'Continuous improvement is part of the culture at Fisher & Paykel Healthcare, and Rajeneel always seeks ways to improve himself and his team.' The annual Plastics NZ Awards salutes those in the industry who are making their mark and Rajeneel is a stellar example. So too is Henderson resident Faleono (Junior) Esekia who stepped up to the podium alongside Rajeneel to take out Competenz Trainee of the Year, the top award for people training in New Zealand Certificate Level 3 qualifications. A plastics technician at product development and manufacturing company Adept Ltd, Junior completed his Level 3 injection moulding qualification last September and is now on the fast track to gaining his apprenticeship. 'I'm shocked and speechless to be named Trainee of the Year,' says Junior (33). 'Having spent over ten years in the plastics industry, receiving this accolade means so much to me, and is the first step towards achieving my goal of gaining my apprenticeship and one day becoming the 'Dr. Murphy' of plastics and injection moulding!' The father of four was inspired to forge a career in plastics after studying science at the University of Auckland. 'Seeing senior plastics technicians being able to mould and fix any issues with injection moulding made me want to be at that level of skill and knowledge. What I love most is that feeling I get when I solve an injection moulding issue and I'm able to get a product to run perfectly – that and getting to try out the new automation being introduced with new products.' Junior's Competenz Training Advisor Jonathan Newsome describes the plastics technician as 'deserving, super helpful, polite and self-driven.' 'Junior completed all his assessments to a high standard, met all his deadlines and drove his qualification himself. The fact that he has now advanced into Level 4 demonstrates the drive he has to better himself,' says Jonathan. Employer Patrick McElhannan has been equally impressed and can't wait to see Junior continue to flourish in the organisation and the industry. 'Junior is the quiet achiever, he consistently demonstrates his ability as a plastics technician. He never seeks recognition but his work ethic and the high standard of work he produces is testament to the calibre of technician he has become. Because of this we as a business can see just how much value he adds daily within the workspace,' says Patrick. 'Junior is now recognised as an equal amongst his peers, and sometimes other more seasoned veterans within the plastics world seek advice from him. His ability to troubleshoot and diagnose root causes in plastics faults, his wide processing knowledge of a large catalogue of polymers, along with his extensive knowledge of programming and processing of automation cells including six axis robots, demonstrates just how far he has come through this apprenticeship.' Patrick says he couldn't think of a more deserving candidate for Competenz Trainee of the Year, adding, 'Junior's attitude towards working in a team, along with his displayed aptitude amongst his peers, really sets the tone for what an incredible individual he is. Any moulding shop in New Zealand would be better off for having him around.'
